Better Health: Smart Health Commentary Better Health (TM): smart health commentary

Article Comments (3)

Why No One Knows What Generic Lipitor Costs

Several days ago, the world’s leading cholesterol-lowering “statin” drug, Lipitor, went generic. Doctors are bearing the brunt of the conversion with little information about what the new drug will cost for their patients.

This, of course, is the plan.

Even the Wall Street Journal which has an excellent “user’s guide” to making the switch from name-brand to generic Lipitor offers little help as it mentions “co-pays” rather than actual drug cost:

How much cheaper will generic Lipitor be?

Insurance copayments should drop considerably, if patients are getting Lipitor or atorvastatin on the generic tier of their health plans. Currently, Lipitor has been on a higher, branded tier for prescription drugs. Copays for branded drugs average either $29 or $49 depending on the tier, according to Kaiser Family Foundation. Copays for generics average $10.

In addition, Ranbaxy Laboratories Ltd, one of the generic manufacturers of generic Lipitor, won concessions to maintain elevated prices for 180 days from the government (a la our own Food and Drug Administration while the Federal Trade Commission stands idly by complaining how consumers are gouged with this arrangement) to assure prices stay high a bit longer.

But if we forget the insurers and copays, how much will the generic drug actually cost consumers?

No one will tell you.

That’s because everyone else has to make sure they make their cut first. Pharmacy benefit managers, the leeches attached to nearly every prescription written today, have to strong-arm their position in the ever-competitive pharmaceutical profit by “pre-negotiating” prices for consumers wed to even more insurance plans with varying deductibles and co-pays.

Even Pfizer, not wanting to exclude itself from the profits inherent to such a non-transparent system is offering it’s own “generic version” through Watson Pharmaceuticals. Theoretically it would be good for the public to have multiple generic manufacturers competing for generic Liptor’s market, driving prices down. However, this natural self-regulating market function cannot occur to the benefit of consumers due to the blocking of actual drug price comparison.

Insisting on tranparent retail pricing of the medication’s pre-insurance costs would greatly facilitate consumer choice of statin in the doctor’s office. Someday, one could imagine a Consumer Reports spreadsheet in the same way they rate appliances and automobiles.

But then again, it seems we can’t do that because it would serve the function of weeding out our hidden pharmaceutical middlemen.

-Wes


You may also like these posts

Read comments »


3 Responses to “Why No One Knows What Generic Lipitor Costs”

  1. Bart L.- Kare360 says:

    This is exactly the type of question we designed Kare360 to answer for patients. Let us get quotes for you from multiple pharmacies and manufacturers to make sure you can make the best decisions without having to spend hours to do it.

  2. Sandy says:

    Yes true, the cost of generic lipitor is not still know, at the same time the generic bio-equivalent of lipitor will still be cheaper than generic lipitor. Bio-equivalent of lipitor 10mg costs $1.21 per tablet and 40mg tablet costs $1.83 per tablet. You can find cost details of diffrent dosages at International Drug Mart.

  3. Sandy says:

    Yes true, the cost of generic lipitor is not still know, at the same time the generic bio-equivalent of lipitor will still be cheaper than generic lipitor. Bio-equivalent of lipitor 10mg costs $1.21 per tablet and 40mg tablet costs $1.83 per tablet. You can find cost details of different dosages at International Drug Mart.

Return to article »

Latest Interviews

IDEA Labs: Medical Students Take The Lead In Healthcare Innovation

It’s no secret that doctors are disappointed with the way that the U.S. healthcare system is evolving. Most feel helpless about improving their work conditions or solving technical problems in patient care. Fortunately one young medical student was undeterred by the mountain of disappointment carried by his senior clinician mentors…

Read more »

How To Be A Successful Patient: Young Doctors Offer Some Advice

I am proud to be a part of the American Resident Project an initiative that promotes the writing of medical students residents and new physicians as they explore ideas for transforming American health care delivery. I recently had the opportunity to interview three of the writing fellows about how to…

Read more »

See all interviews »

Latest Cartoon

See all cartoons »

Latest Book Reviews

Book Review: Is Empathy Learned By Faking It Till It’s Real?

I m often asked to do book reviews on my blog and I rarely agree to them. This is because it takes me a long time to read a book and then if I don t enjoy it I figure the author would rather me remain silent than publish my…

Read more »

The Spirit Of The Place: Samuel Shem’s New Book May Depress You

When I was in medical school I read Samuel Shem s House Of God as a right of passage. At the time I found it to be a cynical yet eerily accurate portrayal of the underbelly of academic medicine. I gained comfort from its gallows humor and it made me…

Read more »

Eat To Save Your Life: Another Half-True Diet Book

I am hesitant to review diet books because they are so often a tangled mess of fact and fiction. Teasing out their truth from falsehood is about as exhausting as delousing a long-haired elementary school student. However after being approached by the authors’ PR agency with the promise of a…

Read more »

See all book reviews »